- Home
- HRMY vs LSPD Comparison
HRMY vs LSPD Comparison
Compare HRMY & LSPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HRMY | LSPD |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HRMY | LSPD |
|---|---|---|
| Price | $35.24 | $11.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 15 |
| Target Price | ★ $50.56 | $13.63 |
| AVG Volume (30 Days) | ★ 934.4K | 688.0K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.44 | N/A |
| EPS | ★ 3.17 | N/A |
| Revenue | $825,944,000.00 | ★ $1,157,458,000.00 |
| Revenue This Year | $20.68 | $14.32 |
| Revenue Next Year | $15.93 | $11.78 |
| P/E Ratio | $11.14 | ★ N/A |
| Revenue Growth | ★ 21.13 | 14.24 |
| 52 Week Low | $25.52 | $7.34 |
| 52 Week High | $40.93 | $18.96 |
Technical Indicators
Market Signals| Indicator | HRMY | LSPD |
|---|---|---|
| Relative Strength Index (RSI) | 71.09 | 43.65 |
| Support Level | $32.77 | $10.68 |
| Resistance Level | $36.20 | $11.16 |
| Average True Range (ATR) | 1.11 | 0.43 |
| MACD | 0.17 | -0.12 |
| Stochastic Oscillator | 81.04 | 18.45 |
Price Performance
Historical ComparisonAbout HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.